Evidence map›Paper›PMID 37081999›Full record

ReviewFrontiers in allergy2023

Do advanced glycation end products contribute to food allergy?

P K Smith, C Venter, L O'Mahony, R Berni Canani, O J L Lesslar

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in allergy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 4 countries.

P K SmithClinical Medicine and Menzies School of Research, Griffith University, Gold Coast, QLD, Australia.
C VenterChildren's Hospital Colorado, University of Colorado, Aurora, CO, United States.
L O'MahonyDepartment of Medicine, School of Microbiology, APC Microbiome Ireland, University College Cork, Cork, Ireland.
R Berni CananiDepartment of Translational Medical Science and ImmunoNutritionLab at CEINGE-Advanced Biotechnologies, University of Naples "Federico II", Naples, Italy.
O J L LesslarCingulum Health, Sydney, NSW, Australia.
Ceinge Biotecnologie Avanzate (Italy) · ITGriffith University · AUUniversity College Cork · IEUniversity of Colorado Anschutz Medical Campus · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sugars can bind non-enzymatically to proteins, nucleic acids or lipids and form compounds called Advanced Glycation End Products (AGEs). Although AGEs can form

Indexed as

advanced glycation end productsalarmincarboxymethyllysine (CML)food allergyhigh molecular group box 1methylglyoxal (MG)receptor for advanced glycation end products (RAGE)

Identifiers

PMID37081999
PMCPMC10111965
OpenAlexW4362554587

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.